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Abstract
Ion transport is essential for maintenance of transmembranous and transcellular electric potential,
fluid transport and cellular volume. Disturbance of ion transport has been associated with cellular
dysfunction, intra and extracellular edema and abnormalities of epithelial surface liquid volume.
There is increasing evidence that conditions characterized by an intense local or systemic
inflammatory response are associated with abnormal ion transport. This abnormal ion transport
has been involved in the pathogenesis of conditions like hypovolemia due to fluid losses,
hyponatremia and hypokalemia in diarrhoeal diseases, electrolyte abnormalites in pyelonephritis of
early infancy, septicemia induced pulmonary edema, and in hypersecretion and edema induced by
inflammatory reactions of the mucosa of the upper respiratory tract. Components of membranous
ion transport systems, which have been shown to undergo a change in function during an
inflammatory response include the sodium potassium ATPase, the epithelial sodium channel, the
Cystic Fibrosis Transmembrane Conductance Regulator and calcium activated chloride channels
and the sodium potassium chloride co-transporter. Inflammatory mediators, which influence ion
transport are tumor necrosis factor, gamma interferon, interleukins, transforming growth factor,
leukotrienes and bradykinin. They trigger the release of specific messengers like prostaglandins,
nitric oxide and histamine which alter ion transport system function through specific receptors,
intracellular second messengers and protein kinases. This review summarizes data on in vivo
measurements of changes in ion transport in acute inflammatory conditions and in vitro studies,
which have explored the underlying mechanisms. Potential interventions directed at a correction
of the observed abnormalities are discussed.
Background
Physiology of ion transport
Ion transport across cell membranes and epithelial cell
layers is the basis for generation of membrane potentials
and provides the osmotic gradients for transmembranous
and paracellular fluid transport. Transport of sodium
[Na+], potassium [K+] and chloride [Cl-] are involved in
maintenance of the membrane potential and Na+ and Cl-
in fluid transport through creation of osmotic gradients.
The main mechanisms for ion transport in the single cell
as well as through epithelial cell layers involve for sodium
the epithelial sodium channel [ENaC], which allows pas-
sive influx of Na+ into the cell through the apical mem-
brane and the sodium potassium ATPase [Na/K ATPase],
which moves Na+ actively out and K+ into the cell in blood
cells and the basolateral membrane of epithelial cells [See
figure 1]. Water follows the so generated osmotic gradient
probably paracellular and through aquaporine water
channels in alveolar epithelial cells, renal tubular cells
and colonocytes. Chloride transport in the apical epithe-
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lial cell membrane is mainly mediated by the cAMP
dependent Cystic Fibrosis Transmembrane Conductance
Regulator [CFTR] chloride channel, which can move chlo-
ride into and out of the cell, and the calcium activated
chloride channels. Calcium activated chloride channels
(CaCCs) complement the function of CFTR in transepi-
thelial chloride and fluid transport [1,2]. Their molecular
nature is uncertain. CFTR and CaCC seem to regulate each
others activity: CFTR activation or increased expression is
associated with a reduction in CaCC function. Regarding
its role in transepithelial chloride and fluid transport most
is known from experiments with airway epithelial cells.
While CFTR regulates basal airway surface liquid [ASL]
homeostasis, CaCCs seem to regulate Cl- secretion and
ASL height acutely and in response to extracellular stimuli
[3].
The Na+/K+- 2Cl-- symporter channel permits co-transport
of sodium and potassium and chloride through the baso
lateral cell membrane in both directions. Other less
important ion transport mechanisms include other apical
Na-coupled transporters, such as Na+/phosphate, Na+/
proton and Na+/amino acid antiports and Na+/glucose
antiport systems which account for a small fraction of
transepithelial sodium and liquid transport. The aims of
this review are to summarize and interpret the current
knowledge on influences of inflammation and its media-
tors on cellular ion transport in an attempt to identify
Components of epithelial ion transport and their interactions [[+] = activating, [-]= inactivating] Figure 1
Components of epithelial ion transport and their interactions [[+] = activating, [-]= inactivating].
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common mechanisms of this interaction across all organ
systems in humans. The review of the current knowledge
may facilitate further research by stimulation of thinking
across the boundaries of ion transport and inflammation
research in separate medical subdisciplines. This is also an
attempt to highlight pathways along which a correction of
inflammation induced abnormalities of ion transport has
been achieved by pharmacological intervention in previ-
ous studies.
Methods
Inclusion and exclusion criteria
The results of investigations of pathophysiological proc-
esses in humans involving inflammation-associated
changes in ion-transport will be summarized. In vitro
studies were only quoted if the investigated process
offered a potential explanation of the processes observed
in humans. Direct effects of microbial pathogens inde-
pendent of an inflammatory process were excluded from
the review. The keywords used for literature search were
"ion transport", which was combined with "inflamma-
tion" and the terms "sodium channel", "chloride chan-
nel", "potassium channel", "CFTR" and "ATPase"
combined with the terms "cytokine", "chemokine", "pros-
taglandin", "leukotriene" and "kinine". Databases
searched were Pubmed, Medline [1951 to present] and
EMBASE [1975 to present]. The reference lists of relevant
articles were also scanned.
Excluded studies
Reports on changes of Na/K ATPase function in skeletal
muscle in endotoxemia in human and animal experi-
ments [4] were excluded as a direct effect of the endotoxin
rather than inflammatory mediators was involved. Studies
of the effects on inflammatory mediators on membrane
ion transport in myocardium are limited to animal and in
vitro studies [5] and the significance of the findings to
humans is unknown. The studies relating to this were
therefore not included. Not included in this review were
the in vitro findings regarding changes in ion transport in
the middle ear epithelium [6] as there are no in vivo data
on humans available supporting a pathophysiological
role of changes in ion transport in middle ear disease.
There were no studies on the interaction of inflammatory
processes and ion transport in pancreas, salivary and
sweat gland and epithelium of the genital tract. There were
no relevant studies on changes of potassium channel
function by inflammatory mediators.
Explanation of methods used to measure ion transport
Nasal potential difference measurement
Nasal potential difference measurements involve the in
vivo measurement of a potential difference [voltage]
between a cutaneous or intravenous electrode and a fluid
perfused electrode in contact to the respiratory epithelium
under the inferior turbinate of the nose. The potential
measured represents the end result of ion transport proc-
esses, which are dominated by sodium transport. On
change of the perfusion fluid to an amiloride [ENaC
blocker] containing fluid the resulting depolarization is
equivalent to the contribution of ENaC function to the
potential. A perfusion with a low chloride or chloride free
solution plus amiloride following this measurement will
activate chloride channels in a normal respiratory epithe-
lium and result in a hyperpolarisation which represents
the ability of the epithelium to secrete chloride and is thus
a measure of chloride channel function.
Short circuit measurement with Ussing chamber
In the Ussing chamber an epithelium is inserted between
two fluid filled chamber halves, which contain electrodes
for stimulation and measurement of current and voltage.
In the short circuit current [Isc] measurement the charge
flow per time through the epithelium [between the two
chamber halves] when the epithelium is short-circuited,
i.e. the voltage clamped to 0 mV, is measured. Ion channel
function is analyzed by measurement of current or voltage
changes in response to blockers and stimulators of ion
channel function. Amiloride is used to block sodium
channels and forskolin, a stimulator of the adenylate
cyclase, which activates CFTR mediated chloride secretion
through increase in intracellular cAMP, is used to test
CFTR function.
Patch clamp electrode measurements
A synonym of this term is continuous single electrode
clamp. A smooth surfaced tip of > 1 micron diameter of a
hollow electrode is pressed against a cell membrane and
suction is applied inside the electrode. This pulls the cell
membrane inside the electrode forming a tight seal. With
the attached electrode currents through ion channels of
the patch can be measured. By taking the patch of mem-
brane out of the cell an "inside out patch" is formed,
which enables the inside of the ion channels to be stud-
ied. An "outside out patch" is created by pulling a mem-
brane ball with the patch out of the cell to study the
properties of ion channels protected from the outside
environment and not exposed to the cell content. "Inside
out" and "outside out" are excised patch modes for single
channel recording. Another variation of the method is the
"perforated patch" by which a recording from the inside
of the cell is taken. In perforated patch recording the
membrane is perforated using fungicides like nystatin.
The resulting situation is electrically similar to whole-cell
recording but prevents washout of cytosolic factors.
125I efflux assay
This assay is used to measure the activity of the CFTR chlo-
ride channel in vitro.Journal of Inflammation 2006, 3:5 http://www.journal-inflammation.com/content/3/1/5
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After incubation of cells with the chloride analogue 125I,
which leads to its uptake into the cells, the gamma radia-
tion in efflux fluid elicited by secretagogues like forskolin
[see above] or ionomycin [a calcium ionophore used to
stimulate calcium activated chloride channels] is meas-
ured. The radioactivity in the cells at a defined point in
time is calculated as the sum of radioactivities released in
subsequent efflux samples and the radioactivity in the
cells at the end of the experiment. The studies are then
conducted with the inhibitor of the outwardly rectifying
chloride channel [ORCC] DIDS (4,4-diisothiocyano-
dihydro stilbene-2-2'-disulfonic acid) and the inhibitor of
both CFTR and the ORCC DPC (diphenylamine-2-car-
boxylic acid or N-phenylanthranilic acid). From the differ-
ence in activity is then the activity of CFTR calculated.
Rubidium 86+ flux studies
Rubidium flux studies measure the activity of the Na/K
ATPase. This is achieved in vitro by measuring the Na/K
ATPase mediated uptake of a potassium analogue, the
gamma radiation emitting isotope Rubidium 86+ into
cells over time. The uptake study involves interruption of
the uptake at defined time points after which the radioac-
tivity of the cell population is measured with a gamma
counter. The Na/K ATPase mediated uptake is measured
by conducting the measurements with and without addi-
tion of ouabain, a specific inhibitor of the Na/K ATPase.
Ion transport in inflammatory diseases of the 
respiratory system
Upper respiratory tract
In patients with pollen allergy the nasal potential differ-
ence, which is a representation of nasal mucosal sodium
transport was reduced in the pollen season compared to
controls. Amiloride sensitive nasal potential difference,
which reflects nasal epithelial sodium channel function
was found to be significantly decreased after allergen chal-
lenge [7]. This supported the hypothesis that epithelial
sodium transport is reduced during allergic inflamma-
tion. The findings may explain the increased epithelial
surface fluid volume in the upper respiratory tract leading
to excessive rhinorrhea in allergic rhinitis. A study on
humans with chronic sinusitis investigated the correlation
of the dynamic visco-elasticity of maxillary sinus fluid and
change in amiloride responsive transmucosal short-circuit
current in the Ussing chamber [8]. A significant positive
correlation between visco-elasticity and sodium channel
channel function was found. This suggested that the con-
centration of epithelial surface liquid volume in the max-
illary sinus in sinusitis is dependent on changes in
transepithelial sodium transport. In vitro studies have
also found a reduction in CFTR gene and protein expres-
sion in chronically inflamed nasal polyps associated with
a reduced cAMP-dependent short ciruit current in the Uss-
ing chamber. This effect was reversible by removal of
transforming growth factor beta 1 (TGF-beta 1) from the
culture medium and could be reproduced by the addition
of TGF-beta 1 to normal nasal mucosa [9].
Lower respiratory tract
In vivo studies of ion transport in humans with systemic
inflammatory response syndrome and pulmonary edema
found evidence of a systemic reduction in epithelial
sodium and chloride transport [10,11]. The studies inves-
tigated meningococcal septicemia induced pulmonary
edema. Chloride channel function in patients with pul-
monary edema was reduced on nasal PD measurements
[See figure 2]. The extent of a reduction of systemic
sodium and chloride transport as reflected in sweat and
salivary sodium and chloride levels correlated signifi-
Nasal potential difference in a child ventilated with meningococcal septicaemia related pulmonary edema Figure 2
Nasal potential difference in a child ventilated with meningococcal septicaemia related pulmonary edema. The graph shows a 
lack of response of chloride channels in airway epithelium to a low chloride solution. This response is restored by the addition 
of the beta receptor agonist isoprenaline to the perfusate [unpublished graph from work published in [11]]. A model of the 
components of the ion transport systems involved has been put next to it: [+] = activating.
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cantly with the severity of respiratory compromise. The
results were compatible with an inhibition of epithelial
chloride transport through the CFTR and a sodium potas-
sium ATPase dysfunction in children with meningococcal
septicemia induced pulmonary edema. Hormonal regula-
tors of the Na/K ATPase like aldosterone, cortisol and thy-
roxine were not decreased in these patients.
Regulation of ion transport protein activity
The CFTR dysfunction may have been related to the Na/K
ATPase dysfunction and previous studies have demon-
strated a reduction of function of the Na/K ATPase in red
blood cells, muscle and liver of patients with septicemia
[12,13]. Inhibition of the Na/K ATPase in human pulmo-
nary Calu-3 cells lead to a reduced transcription of CFTR
[14]. CFTR dysfunction was also induced through Na/K
ATPase inhibition by ouabain in airway epithelial cells in
another experiment [15]. CFTR dysfunction has been
linked to reduced distal airways fluid clearance and fluid
transport across alveolar epithelial type II cells [16,17].
There is evidence that in alveolar epithelial cells as
opposed to upper airways epithelia a reduction in CFTR
function is linked to a reduction in sodium transport
through ENaC, which may contribute to the reduced lung
liquid clearance observed in pulmonary edema. CFTR
activation by cAMP in alveolar epithelial cells has been
shown to be a condition for apical sodium influx into
alveolar epithelial cells through ENaC by hyperpolarisa-
tion [18]. The lack of absorption of sodium associated
with chloride channel dysfunction could explain a
reduced alveolar liquid clearance because of the reduced
osmotic effect drawing water through the alveolar
aquaporin channels [19]. In isolated congenital CFTR dys-
function (cystic fibrosis) an increase in sodium transport
by an increase in apical ENaC and basolateral Na/K
ATPase activity in the airways can compensate for a reduc-
tion in alveolar chloride and sodium transport. In septi-
cemia associated pulmonary edema this compensation is
prevented by additional inhibition of the Na/K ATPase.
Patients with septicemia generate high levels of pro-
inflammatory cytokines like tumor necrosis factor [TNF]
[20]. Studies in animal models of pulmonary edema
found that tumor necrosis factor has a dichotomal role in
its activity on sodium transport and pulmonary edema
reabsorption [21]. Some studies found that incubation
with TNF was associated with a reduction in alveolar epi-
thelial cell sodium transport in vitro while others found
that in an in vivo model of bacterial pneumonia in rats
TNF increased alveolar fluid clearance. The enhancing
effect of pneumonia with its high pulmonary TNF levels
on alveolar fluid clearance was reduced by blockage of
ENaC by amiloride [22]. This contradiction was recently
resolved in a study in a rat model, in which TNF, when
complexed with the soluble TNF receptor 1 construct
[sTNFR1], increased alveolar fluid clearance via a lectin
binding structure but without sTNFR1 it inhibited liquid
clearance. STNFR1 seemed to modulate TNF function by
diverting it from classical TNF receptors to an alternative
receptor activating ENaC [21].
IL-1beta was found to antagonize the effects of prostag-
landin E2 [PGE2] which stimulated chloride transport in
canine tracheal epithelium and in Calu-3 bronchial epi-
thelial cells by inducing excess production of PGE2. This
lead to a down regulation of EP4 prostanoid receptors and
subsequently to a reduction of PGE2 induced cAMP pro-
duction. Reduced intracellular cAMP levels then lead to a
reduction in cAMP dependent CFTR function [See figure
1] [23]. IL-1beta was also found to reduce ENaC function
in human bronchial epithelial cells without reducing
ENaC expression [24]. Another inflammatory mediator
associated with reduced alveolar sodium transport and
fluid clearance is nitric oxide [NO]. It is active by an
unknown mechanism, which may involve an inhibition
of the adenylate cyclase. This may, through inactivation of
the Na/K ATPase, lead to a reduction of alveolar epithelial
fluid transport [25]. NO is released by distal lung epithe-
lial cells and alveolar macrophages in response to proin-
flammatory cytokines like IL- 1beta, TNF and interferon
gamma [IFN gamma] [26-29].
More recently it has been recognized that the lipoxygenase
product leukotriene D4 increases alveolar epithelial
sodium transport and fluid clearance by activation of the
lung Na/K ATPase [30].
Previous investigations into the influence of inflamma-
tory mediators on respiratory epithelial chloride transport
in vitro have demonstrated that PGE2 released in
response to bradykinin [31], eosinophil major basic pro-
tein [32] and leukotrienes C4 and D4 [33] appeared to
increase chloride secretion in the canine tracheal epithe-
lium using short-circuit current measurments in the Uss-
ing chamber. Leukotriene D4 seemed to be most effective.
NO has been shown to activate non-CFTR chloride cur-
rents [perforated patch clamp technique] via a cyclic gua-
nosine monophosphate [cGMP] dependent mechanism
[34]. Other inflammatory mediators increasing chloride
secretion have been reviewed [35] and include vasoactive
intestinal peptide, which is the most abundant peptide in
the human lung [36], substance P [37-39] and the neuro-
kinins A and B [40]. The exact mechanism and channels
involved are however unknown.
A new pathway for prostaglandin E2 release and stimula-
tion of respiratory epithelial chloride secretion has been
revealed recently: Activated mast cells can by secretion of
tryptase stimulate protease activated receptors type 2
[PAR2] in airway epithelial cells [41]. PAR2 are induced
by TNF and IL-1 [42]. Stimulation of these receptors leadJournal of Inflammation 2006, 3:5 http://www.journal-inflammation.com/content/3/1/5
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directly and mediated through PGE2 release to an activa-
tion of calcium activated chloride channels in mouse and
human airway epithelial cells [43].
Regulation of transport protein expression
Prolonged exposure of alveolar epithelial cells to TNF
alpha by in vitro incubation [24hours], a condition which
is known to change the physiological properties of alveo-
lar epithelial cells significantly [19] seemed to reduce
ENaC mRNA expression without impact on Na/K ATPase
expression [44]. Similarly both IL-1beta and TGF- beta1
seemed to reduce alveolar epithelial sodium uptake in
alveolar type II cells by reduction of expression of the
alpha subunit of ENaC [45,46]. In the preterm fetal
guinea pig lung however IL-1 beta increased both ENaC
and Na/K ATPase expression [47]. Another group reported
a TGF- beta1 induced increase in ENaC function as meas-
ured by short circuit current in rat alveolar epithelial cell
monolayers without increase in expression of ENaC but
an increase in expression of Na/K ATPase [48].
A reduction of beta and gamma units but not the alpha
unit of ENaC was found to be an effect of IL-4 in vitro and
this was associated with inhibition of the amiloride-sensi-
tive Na+  channel as measured in short circuit current
experiments [49]. This cytokine is also a potent upregula-
tor of CFTR protein expression and function in vitro
[49,50]. Another cytokine, which was found to increase
CFTR expression in human bronchial epithelial cells is IL-
1 beta and this was associated with an increase in short cir-
cuit current in the Ussing chambers [24]. Antagonistic
effects may have IFN gamma because short-circuit current
measurements in the Ussing chamber of bronchial epithe-
lial cells showed that it decreases CFTR dependent chlo-
ride secretion significantly, which was associated with a
reduction in CFTR mRNA [49]. IFN gamma has on the
other hand been found to activate non CFTR- chloride
channel activity by stabilization of mRNA transcripts in
human Calu-3 lung epithelial cells with an associated
increase in short-circuit current in the Ussing chamber
[51]. Expression of CaCC was found to be increased in
response the Th2 cytokines IL-4, 9 and 13 in human pri-
mary lung culture systems [52].
Ion transport in gastrointestinal inflammatory 
disease
Infective and noninfective causes of diarrhoea have been
associated with fluid and electrolyte losses leading to
dehydration, hypovolemia, hyponatremia and hypokale-
mia [53,54]. This is indicative of an impaired gastrointes-
tinal epithelial ion transport in these conditions.
While secretory diarrhoea is caused by a direct effect of
toxins on epithelial ion transport, mainly via cAMP medi-
ated activation of luminal CFTR and the associated inacti-
vation of ENaC, studies indicated that intestinal ion
transport in inflammatory diarrhoea is changed by effects
of inflammatory mediators on CFTR, ENaC and Na/K
ATPase. The effects of these inflammatory mediators are
transmitted through more complex processes involving
membrane receptors, second messengers and changes in
mRNA transcription.
Regulation of ion transport protein activity
A common pathway for a change in ion transport in both
infective [caused by bacteria like Yersinia sp., E. coli and
Listeria] and noninfective [ulcerative colitis and Crohn's
disease] types of inflammatory diarrhoea has recently
been clarified. All forms of inflammatory diarrhoea are
associated with hypersecretion of chloride into the gut
lumen by activation of CFTR at the apical membrane of
colonocytes drawing water with it by osmotic effects. Acti-
vated CFTR can inhibit ENaC [55] and therefore sodium
absorption in the gut and this may be the main mecha-
nism of fluid loss in diarrhoea by reduction in sodium
driven fluid absorption. Illustrated was the importance of
sodium absorption by the result of investigations of T-cell
activation induced diarrhoea in mice. The investigations
demonstrated that TNF and not IFN gamma mediated an
inactivation of the Na/K ATPase. This effect was independ-
ent of nitric oxide and was present in mice without func-
tional CFTR [56].
In the human colonic T84 cell line Na/K ATPase was
inhibited by IFN gamma and NO and this was associated
with an increase in cell volume and intracellular sodium
concentration [57]. These contradictory findings may
indicate species differences in the response to cytokines or
represent a response to changes in cellular phenotype fol-
lowing in vitro incubation. Inhibition of the Na/K ATPase
by IFN gamma was also observed in murine small intes-
tine preparations and the intestinal epithelial Caco-2 cell
line [58,59]. These effects were not mediated by NO in the
murine intestinal preparation [58].
The pro-inflammatory cytokine TNF caused in ex vivo
human colonic mucosa with attached submucosa an
increase in chloride and potassium secretion, which was
found to be dependent on the effect of prostaglandin E2
[60]. The PGE2 mediated effect of TNF and also of IL-1
beta and IL-3 in increase of intestinal chloride secretion
was confirmed in studies in which cryptosporidium
infected pig ileum and untreated chicken intestine was
found to respond with increased short circuit current to
these cytokines. The increase in short circuit current in
these experiments was blocked by cyclooxygenase inhibi-
tors.
The investigators found that colonic intestinal cell monol-
ayers [T84 cell line] required comounting with TNF stim-Journal of Inflammation 2006, 3:5 http://www.journal-inflammation.com/content/3/1/5
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ulated jejunal fibroblasts to generate an increased short
circuit current, which was sensitive to PGE2 inhibition.
This indicated that fibroblasts may also be involved in
changes in epithelial ion transport in inflammatory bowel
disease [61,62]. PGE2 was also involved in the effects of
the proinflammatory neuropeptide substance P in an
increase in chloride secretion measured in an Ussing
chamber experiment in the rabbit colonic mucosa. The
effect of substance P was hereby dependent on mast cell
activity and histamine [63]. Another pathway of induc-
tion of PGE2 release in the gut is through NO and leuko-
triene D4, which both stimulated prostaglandin release
[64,65]. PGE2 activated chloride secretion via its effect on
vacuolated columnar colonic epithelial cells [66]. This
effect was mediated through cAMP activated protein
kinase A (PKA), which activated CFTR. Amongst all pros-
taglandins only PGE2 and PGF2 were found to stimulate
chloride secretion in rabbit distal colonic mucosa via
cAMP in this context [67].
In the gut NO increased intracellular cGMP levels, a sec-
ond messenger, which induced Cl -secretion by stimula-
tion of CFTR through cGMP-regulated protein kinase G
type II [68]. Nitric oxide donors were able to stimulate
chloride secretion in human colonic mucosa [69].
Another mediator, which increased chloride secretion in
T84 human intestinal cell monolayers, is the neutrophil
derived 5'adenosine monophosphate which after conver-
sion to adenosine acted on adenosine receptors on the
apical membrane [70,71].
Cytokines which enhanced cAMP mediated chloride
secretion in human small intestinal ex vivo preparations
were IL-2 and IL-15 [72].
Recently a new mechanism for stimulation of chloride
secretion has been investigated. It involved the induction
and activation of the proteinase activated receptor type 2
in epithelial cells by intestinal mast cells leading to activa-
tion of chloride channels by the same mechanism as
found in the respiratory tract [41] [see above]. The essen-
tial role of mast cells in changes of ion transport in
response to allergic inflammation has been confirmed by
a study in which jejunal mucosa from rats responded with
an increase in short-circuit current to antigen, a response
which was inhibited by a chloride channel blocker and
mast cell stabilizers [73]. Another group reported that the
activation of chloride transport as measured by short cir-
cuit measurement in allergic inflammation in guinea pig
colon was dependent on a pathway containing both his-
tamine and prostaglandin [74].
IL-4 and IL-10 seem to counteract effects of pro-inflam-
matory mediators on chloride secretion in the gut. They
have been found to diminish Cl–secretion, as measured by
epithelial short ciruit current in the Ussing chamber [75-
77]. IL-10 reduced chloride secretion by reduction of
intracellular cAMP and mediated increased sodium and
chloride absorption as measured under voltage clamp
conditions in the Ussing chamber in rat small intestine
[76]. IFN gamma was also found to inhibit chloride secre-
tion [58,78]. Sodium and chloride secretion was increased
by addition of histamine, which acted via H1-receptors in
porcine distal colon epithelial cells in the Ussing chamber
[79]. TNF was found to potentiate histamine induced ion
secretion in the HT29cl.19A cells and mouse distal colon
[80]. However the response of the short circuit current to
mast cell mediators was found to be decreased in human
small and large bowel mucosa-submucosa preparations
treated with histamine suggesting interspecies differences
[81].
Regulation of transport protein expression
Experiments with the gut derived epithelial cell lines T84
and HT-29 showed that interferon gamma and TNF both
independently and if applied together synergistically,
reduce CFTR mRNA by destabilization of transcripts and
with prolonged [> 24 hour] exposure also CFTR protein
on the cell surface. This process seemed to reduce the
chloride current [82]. Other cytokines which have been
found to reduce CFTR mRNA and intracellular CFTR pro-
tein expression and integration in the apical membrane
leading to a reduced epithelial secretory response in
colonic epithelia [T84 and HT-29] were TGF beta 1 and
interleukin-4 [83]. Other studies have demonstrated a NO
induced reduction in chloride secretion, which appears to
be related to an inhibition of cAMP dependent CFTR traf-
ficking inside intestinal epithelial cells [84]. Colitis in rats
was associated with a long term increase in inducible NO-
synthetase expression leading to persistently reduced
chloride secretion in response to stimuli [85].
A dichotomous effect on CFTR expression was noted for
Interleukin 1beta. It upregulated CFTR mRNA levels at a
dose of 0.25 ng/ml and inhibited CFTR mRNA and pro-
tein expression at higher doses [1 ng/ml] in T 84 cells [86].
This cytokine increased protein expression of the Na K 2Cl
symporter and reduced Na/K ATPase protein expression
in another experiment [87]. TNF was found to have the
opposite effect on Na K 2Cl symporter expression in rat
colon where it reduced both Na/K ATPase and Na K 2Cl
symporter expression and activity in surface and crypt
colonocytes [88]. This effect was dependent on PGE2 and
inhibitable by indomethacin. In an ex vivo human
colonic mucosa plus submucosa preparation of patients
with ulcerative colitis aldosterone was unable to stimulate
electrogenic sodium transport in the Ussing chamber or
ENaC mRNA levels and protein expression [See figure 3].
This lack of response to aldosterone could be reproduced
by incubation of healthy human colonic tissue with TNFJournal of Inflammation 2006, 3:5 http://www.journal-inflammation.com/content/3/1/5
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and IFN gamma, which reduced electrogenic sodium
transport and lead to a reduced upregulation of ENaC
mRNA [89]. Another group reported that the expression
of beta-and gamma-subunits of ENaC was inhibited by
both TNF and IL-1 beta in rat distal colon. IFN gamma
had no effect on ENaC expression in this study [90].
IFN gamma reduced Na/K/2Cl-cotransporter and Na/K
ATPase expression without altering CFTR levels in T84
intestinal epithelial cells [91]. Another study however
noted that interferon gamma reduced Na/K ATPase activ-
ity without change in Na K ATPase expression in human
intestinal Caco-2 cells [59].
This may explain the dysfunction of the apical Na+ -glu-
cose cotransport found in the chronically inflamed rabbit
ileum for which these basolateral pumps are essential for
creating a sodium gradient [92]. Interleukin-4 in contrast
to the genetically closely linked interleukin -13 was able
to reduce chloride secretion as assessed by 125 I efflux assay
by down regulation of CFTR expression in the human
intestinal cell line T84 in vitro [93].
Ion transport in pyelonephritis
In a retrospective study of 300 children with urinary tract
infection 6.8% were noted to have significant
hyponatremia and hyperkalemia [94]. This phenomenon
has been investigated further and fractional renal potas-
sium excretion and transtubular potassium concentration
gradient were found to be reduced in children with
pyelonephritis [95]. This condition, which resolved on
recovery, was termed transient pseudohypoaldosteronism
as aldosterone levels were found to be normal or elevated
[96].
Regulation of ion transport protein activity
The underlying mechanism is related to an impairment of
renal sodium and potassium transport by inflammatory
mediators. Interleukin-1 infusion was found to induce
natriuresis in rats [97]. In vitro studies on inner medullary
collecting duct cells showed that IL-1 was able to reduce
the ouabain sensitive Rb 86+ flux indicating a reduction in
Na/K ATPase activity [98]. The same was found for an
interaction of endothelial cells and the proximal tubular
epithelial cells in their vicinity in a co-culture experiment
where endothelial derived IL-1 and bradykinin, mediated
by NO and cGMP, reduced sodium transport by down reg-
ulation of Na/K ATPase activity [99]. The effect of IL-1 was
inhibited by a cyclooxygenase inhibitor [indomethacin],
suggesting that the effect is mediated by prostaglandins
[100]. PGE2 inhibited the Na/K ATPase in inner medul-
lary collecting duct cells and cortical collecting duct in
vitro [101,102]. PGE2 was also found to lead to cellular
edema in isolated perfused rabbit collecting duct cells, an
effect seen with the known Na/K ATPase inhibitor oua-
bain. This effect of PGE2 seemed to vary across different
anatomical sections of the renal tubule: In the rat kidney
medullary Na/K ATPase was only moderately suppressed
while a more significant suppression was found in the
thick ascending limb of the loop of Henle [103].
It has been suggested that PGE2 doesn't act directly on the
Na/K ATPase but through action on apical Na+ entry.
Patch clamp experiments showed that PGE2 reduced the
open probability of apical sodium channels in rabbit cor-
tical collecting tubules. This effect involved the release of
inositolphosphate-3-sensitive intracellular calcium stores
and calcium dependent activation of the apical mem-
brane protein kinase C [104].
More potent directly inhibitory effects on the Na/K
ATPase seem to come from substances which increase
intracellular cAMP. The most important examples are
epoxides, which are arachidonic acid metabolites of the
cytochrome P450-dependent monooxygenase pathway,
like 11,12 -dihydroxyeicosatrienoic acid, 5,6-eoxyeicosa-
trienoic acid and 12 [R]-hydroxyeicosatetraenoic acid
[105].
The effect of nitric oxide on ion transport in the nephron
has been reviewed recently [106]. One group reported
that in rat kidney medullary slices NO donors mediated
by cGMP and proteinkinase G inhibited Na/K ATPase
activity [107]. This suggested that cytokine induced NO
Short-circuit measurements on healthy colonic mucosa and  mucosa of a patient with ulcerative colitis [UC] Figure 3
Short-circuit measurements on healthy colonic mucosa and 
mucosa of a patient with ulcerative colitis [UC]. Shown is the 
response of the short circuit current (ISC) to aldosterone 
[upregulator of ENaC and Na/K ATPase function] and amilo-
ride [ENaC blocker] [Taken with permission from [89].Journal of Inflammation 2006, 3:5 http://www.journal-inflammation.com/content/3/1/5
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may be involved in changes in renal sodium and potas-
sium transport.
In vivo studies have demonstrated that bradykinin is
another potent natriuretic agent. This effect is mediated by
inhibition of ENaC and Na/K ATPase activity possibly
mediated by an increase in intracellular calcium and/or
pH. Bradykinin seemed to counteract the stimulatory
effect of Angiotensin [1-7] on the Na/K-ATPase activity of
the basolateral membrane of the proximal tubule through
a pathway involving phospholipase A2 and PGE2 [108].
Bradykinin revealed dichotomous effects in another study
where it was found to increase Na/K ATPase activity
through interaction with B1 bradykinin receptors but
inhibited Na/K ATPase function by interaction with the
B2 bradykinin receptors on renal proximal tubular cells in
vitro [109].
Regulation of transport protein expression
IL 1beta inhibited protein expression of Na/K ATPase in
medullary and cortical rat kidney cells and this effect was
mediated by the extracellular signal regulated protein
kinase pathway which activated the nuclear factor NF-kap-
paB, thus leading to increased cycloxyenase-2 [COX-2]
expression and PGE2 release. PGE2 in turn inhibited NF-
kappaB and reduced the protein expression of Na/K
ATPase [100]. Another explanation for a reduced Na/K
ATPase activity in inflammatory renal disease provided
the finding of a reduced binding of aldosterone to lym-
phocytes of patients with pyelonephritis [110]. A reduced
aldosterone effect on tissues could lead to a reduction of
Na/K ATPase expression and activity.
An increase in expression of apical amiloride-blockable
Na+ channels was observed in a distal nephron cell line
[A6] not after short [3–6min] but prolonged [10–50min]
stimulation with PGE2. Short stimulation resulted in a
reduced opening probability of sodium channels [111].
PGE2 also decreased the expression of the Na/K/2Cl
cotransporter in mouse medullary thick ascending limb
cells as measured by specific [3H] bumetanide binding
[112].
Very little data are available for influence of cytokines on
renal chloride transport. TGF beta1 was found to lead to
perinuclear accumulation of CFTR protein and reduced
chloride secretory responses to cAMP stimulating agents
[82]. Bradykinin activated CaCCs in whole cell patch
clamp experiments in mouse inner medullary collecting
duct epithelium and this was associated with an increase
in mRNA expression of this channel [113]. The basola-
teral PAR2 induced chloride secretion by CaCCs in M-1
mouse renal cortical collecting duct cells in short circuit
experiments [114]
Effects of changes in ion transport on 
inflammatory mediator production
Before considering interventions in the pathophysiologi-
cal processes leading to changes in ion transport in
inflammatory conditions, the physiological effect of a
change in ion transporter function on inflammatory
mediators needs to be considered. In vitro studies have
investigated the effects of CFTR dysfunction in cystic
fibrosis [CFTR mutation] patients on cytokine secretion in
white blood cell and respiratory epithelial cell popula-
tions. Experiments revealed that blood mononuclear cells
and lymphocytes with CFTR dysfunction exhibited a
reduced potential for secretion of the cytokines IL-10 and
IFN gamma [115,116]. The basal level of IL-8 secretion in
monocytes from cystic fibrosis patients was significantly
increased in vitro and the 50% effective concentrations for
LPS-induced IL-8 production for both CF patients and
obligate heterozygotes were 100-fold lower than in con-
trols [117]. In a human pulmonary epithelial cell line
bearing the Delta F508 mutation of CFTR resulting in a
dysfunctional CFTR chloride channel, PGE2 secretion was
significantly increased. This PGE2 release was attenuated
by the experimentally induced retrafficking of the Delta
F508-CFTR to the plasma membrane [118]. On the other
hand the chloride channel blocker 5-nitro-2- [3-phenyl-
propylamino]-benzoic acid was able to inhibit PGE2
secretion in rat renal glomerular mesiangial cells in vitro
[119]. Expression of epithelial inducible nitric oxide syn-
thase and NO production was reduced in a human trachea
epithelial cell line where CFTR activity was blocked by the
over-expression of the CFTR regulatory domain. This was
confirmed in CFTR deficient mice in vivo [120]. CFTR was
moreover found to increase RANTES expression inde-
pendently of its function as a chloride channel in bron-
chial cell lines [121,122].
These findings of changes in inflammatory mediator pro-
duction related to CFTR dysfunction demonstrate that
therapeutic modifications of ion transport abnormalities
explained below may have an impact on the physiology of
inflammatory processes.
Interventions to modify ion transport
Interventions which modify ion transport in inflamma-
tory disease can be directed at a reduction of production
or activity of cytokines, their messengers like prostagland-
ins and nitric oxide and ion channels directly or through
second messengers. Interference with the cytokine or
chemokine network could interfer with their beneficial
effects.
To overcome this a synthetic peptide [tip peptide] mim-
icking the lectine like domain of TNF has been con-
structed and was found to increase edema absorption
[123]. Topical application of cytokines, hormones or hor-Journal of Inflammation 2006, 3:5 http://www.journal-inflammation.com/content/3/1/5
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mone analogues, which directly or indirectly affect the
function of ion transport systems can counteract the
effects of inflammatory mediators on ion transport with-
out weakening the systemic immune response. An exam-
ple is epidermal growth factor [EGF], which has been
shown to increase cAMP stimulated ENaC mediated
sodium transport in the mouse model of colitis. The effect
was achieved partly by increase of trafficking of ENaC con-
taining intracellular vesicles to the apical membrane lead-
ing to increased insertion of the channel and partly by
activation of ENaC through extracellular signal-regulated
kinase, phosphatidylinositol 3-kinase and protein kinase
C [124]. This can explain the reduction in diarrhoea in
colitis, which was achieved by administration of EGF ene-
mas in patients suffering from ulcerative colitis [125].
The beta-agonist isoprenaline has been shown to reverse
chloride channel dysfunction in nasal respiratory epithe-
lium in meningococcal septicemia related pulmonary
edema in vivo [see figure 2]. Experiments with alveolar
epithelial cells in vitro have demonstrated that CFTR in
these cells can be activated by the beta agonists terbutaline
[126], which is available as an aerosol for application in
patients and licenced as asthma treatment. The mecha-
nism for this effect has been investigated recently in the
Calu-3 human bronchial epithelial cell line and involves
stimulation of the adenylate cyclase by isoprenaline via
beta-2 receptors [See ion transport model in figure 2]. The
adenylate cyclase increases cAMP levels, which activate
CFTR via proteinkinase A. IL-1beta has been found to
enhance this isoprenaline induced cAMP accumulation
through an up regulation of beta-2-receptors [23]. With
regards to conditions with excessive CFTR function it is
promising that nonsteroidal anti-inflammatory drugs
including aspirin, ibuprofen and indomethacin reduced
CFTR transcripts and subsequently cAMP-stimulated
anion fluxes in T-84 colonic cell lines [127].
In the lung beta-agonists and dopamine have also been
shown to improve sodium and the associated fluid trans-
port in pulmonary oedema [128,129]. This is for beta ago-
nists achieved by cAMP mediated activation of Na/K
ATPase function and subsequently ENaC function.
Other hormones able to upregulate Na/K ATPase levels in
cell membranes are glucocorticoids, insulin and thyroid
hormones [130,131] but they have not been investigated
for their effects on lung fluid clearance. Gene transfer of
the beta1 subunit of the Na/K ATPase into rat lungs using
electroporation increased lung liquid clearance signifi-
cantly [132].
Conclusion
General principles of the interaction of inflammatory 
mediators with epithelial ion transport systems
Changes in ion transport were associated with inflamma-
tion due to allergy, auto-immune disease and infection.
This means that not the etiological agents but mediators
of inflammation, which are found in all types of inflam-
matory disease are involved in the changes in ion trans-
port.
In respiratory tract, gut and kidneys pro-inflammatory
cytokines are involved in down regulation of sodium
transport. This down regulation affects not only protein
function but also gene expression of ENaC and/or Na/K
ATPase. This effect on function and gene expression is
mediated by PGE2 and/or NO [See table 1]. PGE2 sup-
ports the inhibition of ENaC at the apical cell membrane
by inducing a concomitant reduction in the activity or
expression of the Na/K ATPase at the basolateral mem-
brane. In all tissues the reduction in sodium transport was
found to be refractory to normal or increased levels of
aldosterone. Influences of inflammatory mediators on
chloride transport have been detected in pulmonary, gut
and kidney cells. Where investigated PGE2 seemed to
simultaneously activate chloride transport and reduce
sodium transport. The PAR2 receptor system seemed to be
involved in regulation of chloride transport in all organ
systems. Messengers involved in translating the signal of
inflammatory mediators intracellularly are cAMP and
cGMP leading both to protein kinase mediated modula-
tion of CFTR-and Na/K ATPase function.
Directions for future research
This review reveals the need for more research into most
aspects of the interaction of pro-and anti-inflammatory
mediators and ion transport systems. Table 1 shows that
many mediators have only been investigated for their
impact on ion transport in one organ system and not in
other systems where they may be equally or more impor-
tant in regulation of sodium and chloride transport in
health and disease. The ion channels targeted by inflam-
matory mediators like VIP, neurokinins A and B and eosi-
nophil major basic protein have not been identified yet
and analysis of the interactions involved requires further
research. Contradictory findings in cytokine effects on epi-
thelial ion transport, which have been resolved for TNF
[regulation by TNF receptor], IL-1beta [dependency on
concentration and presence of a beta agonist] and brady-
kinin [presence of B1 or B2 bradykinin receptor], need to
be addressed for other mediators. TGF beta1 has been
found to increase ENaC function in some but decrease
ENaC function in other experiments on alveolar epithelial
cells. NO seemed to increase chloride secretion in colono-
cytes in one study but reduced it in intestinal cells in
another experiment. Interleukin-4 increased expression ofJ
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Table 1: Effects of inflammatory mediators on epithelial ion transport protein activity and expression.
Type of ion transport
 system [references]
Respiratory tract Gut Kidney
TNF IL-1 IL-4 IL-9 IL-13 IFNg TGF Leukotrienes TNF IL-1 IL-3 IL-4 IL-10 IFNg TGF Subst P bradykinin IL-1 TGF bradykinin epoxide
CFTR
activity
[9,23,24,49,50,82,83,93]
+/- a,b +- - + a + a,b + a,b + a ----+   a,c +-
expression
[9, 24, 49, 50, 82, 83, 86, 
93]
++ -- - + / - - - - -
ENaC
activity
[21, 24, 45, 46, 48, 49]
+/- 
a,b
-- + -
expression
[44, 45, 46, 47, 49, 89, 
90]
-+ / -- - -- -
Na/K ATPase
activity
[30, 56, 57, 58, 59, 88, 
98, 99, 108, 109]
+a -- - - a,b +/-a -
expression
[47, 48, 87, 88, 91, 100]
++ - a -- -
Non CFTR Cl-channel
activity [51, 133] + + + +
expression [51, 52, 113] + + + + +
Na/K 2Cl-co-
transporter
-
activity [88] -
expression [87, 88, 91] -a +-
+ = increase
-=decrease
+/- = increase or decrease depending on experimental conditions and possibly second messenger involved
a mediated through PGE2
b mediated through NO
c mediated through histamineJournal of Inflammation 2006, 3:5 http://www.journal-inflammation.com/content/3/1/5
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CFTR in lung epithelial cells but decreased its expression
in colonic epithelial cell lines. A detailed understanding of
potential dichotomous effects of inflammatory mediators
may, as illustrated above for TNF, lead to a deeper under-
standing of the pathophysiology of ion transport in
inflammatory disorders and open avenues for new thera-
peutic approaches.
The relative importance of each of the numerous inflam-
matory mediators involved in regulation of ion transport
needs to be clarified for each type of ion transport system
and the various organsystem by comparative studies. This
will facilitate the therapeutic targeting of the most impor-
tant pathophysiological processes. Topical therapies in
the colon and lungs may be able to deliver agents counter-
acting undesirable effects of inflammatory mediators on
epithelial ion transport without systemic side effects. This
may lead to supportive therapies directed specifically at a
correction or prevention of the abnormal fluid and elec-
trolyte shifts found in inflammatory diseases affecting
these organ systems.
Abbreviations
cAMP Cyclic adenosine monophosphate
cGMP Cyclic guanosine monophosphate
CaCC Calcium activated chloride channel
CFTR Cystic fibrosis transmembrane conductance regula-
tor
COX-2 Cyclooxygenase-2
EGF Epithelial cell growth factor
ENaC Epithelial sodium channel
IFNg Interferon gamma
IL Interleukin
Na/K ATPase Sodium potassium adenosine triphos-
phatase
NO Nitric oxide
PAR2 proteinase activated receptor type 2
PGE2 Prostaglandin E2
PK Protein kinase
RANTES Regulated upon activation, normal T-cell
expressed and secreted
Rb Rubidium
TGF Transforming growth factor
TNF Tumor necrosis factor alpha
TNFR Tumor necrosis factor receptor
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